Literature DB >> 26610681

[Combined PET-MRI of the abdomen].

Tibor Vag1, M Eiber2, M Schwaiger2.   

Abstract

The first fully integrated combined positron emission tomography-magnetic resonance imaging (PET-MRI) scanners have been clinically available since 2010. Large prospective studies regarding indications and diagnostic accuracy of this new modality are not yet available; however, preliminary studies have shown a higher diagnostic accuracy and confidence compared to PET-computed tomography (PET-CT) in regions where MRI is known to be superior to CT, such as the liver. The benefit of MRI in accurate lesion characterization and the additional value of diffusion-weighted imaging (DWI) as a complementary functional modality by means of the apparent diffusion coefficient (ADC) is apparent in entities with low tracer uptake (e.g. due to small size) and a decreased or absent accumulation pattern on PET.

Keywords:  Abdomen; Colorectal cancer; Liver metastases; Neuroendocrine tumors; Positron emission tomography-computed tomography

Mesh:

Year:  2015        PMID: 26610681     DOI: 10.1007/s00117-015-0046-x

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  25 in total

1.  Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis.

Authors:  Eisar Al-Sukhni; Laurent Milot; Mark Fruitman; Joseph Beyene; J Charles Victor; Selina Schmocker; Gina Brown; Robin McLeod; Erin Kennedy
Journal:  Ann Surg Oncol       Date:  2012-01-20       Impact factor: 5.344

2.  Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis.

Authors:  Shandra Bipat; Saffire S K S Phoa; Otto M van Delden; Patrick M M Bossuyt; Dirk J Gouma; Johan S Laméris; Jaap Stoker
Journal:  J Comput Assist Tomogr       Date:  2005 Jul-Aug       Impact factor: 1.826

3.  Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma.

Authors:  S Shiomi; S Nishiguchi; H Ishizu; Y Iwata; N Sasaki; A Tamori; D Habu; T Takeda; S Kubo; H Ochi
Journal:  Am J Gastroenterol       Date:  2001-06       Impact factor: 10.864

4.  Nodal staging of rectal cancer: high-resolution pelvic MRI versus ¹⁸F-FDGPET/CT.

Authors:  Dae Jung Kim; Joo Hee Kim; Young Hoon Ryu; Tae Joo Jeon; Jeong-Sik Yu; Jae-Joon Chung
Journal:  J Comput Assist Tomogr       Date:  2011 Sep-Oct       Impact factor: 1.826

5.  Application of classification trees for the qualitative differentiation of focal liver lesions suspicious for metastasis in gadolinium-EOB-DTPA-enhanced liver MR imaging.

Authors:  J Schelhorn; M Benndorf; M Dietzel; H P Burmeister; W A Kaiser; P A T Baltzer
Journal:  Rofo       Date:  2012-05-22

6.  Metabolic restaging of hepatocellular carcinoma using whole-body F-FDG PET/CT.

Authors:  Long Sun; Yong-Song Guan; Wei-Min Pan; Zuo-Ming Luo; Ji-Hong Wei; Long Zhao; Hua Wu
Journal:  World J Hepatol       Date:  2009-10-31

Review 7.  Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.

Authors:  Anna Maria De Gaetano; Vittoria Rufini; Paola Castaldi; Anna Maria Gatto; Laura Filograna; Alessandro Giordano; Lorenzo Bonomo
Journal:  Abdom Imaging       Date:  2012-12

8.  Computerized analysis of enhancement kinetics for preoperative lymph node staging in rectal cancer using dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Tibor Vag; Julia Slotta-Huspenina; Robert Rosenberg; Franz G Bader; Ulrich Nitsche; Enken Drecoll; Ernst J Rummeny; Jochen Gaa
Journal:  Clin Imaging       Date:  2014-06-19       Impact factor: 1.605

9.  The clinical use of PET with (11)C-acetate.

Authors:  Ilaria Grassi; Cristina Nanni; Vincenzo Allegri; Joshua James Morigi; Gian Carlo Montini; Paolo Castellucci; Stefano Fanti
Journal:  Am J Nucl Med Mol Imaging       Date:  2011-12-15

10.  Lesion-based analysis of (18)F-FDG uptake and (111)In-Pentetreotide uptake by neuroendocrine tumors.

Authors:  Kazuo Kubota; Momoko Okasaki; Ryogo Minamimoto; Yoko Miyata; Miyako Morooka; Kazuhiko Nakajima; Takashi Sato
Journal:  Ann Nucl Med       Date:  2014-09-02       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.